|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0005516,
umls-concept:C0013216,
umls-concept:C0017262,
umls-concept:C0040085,
umls-concept:C0185117,
umls-concept:C0220901,
umls-concept:C0681890,
umls-concept:C0814225,
umls-concept:C1522673,
umls-concept:C1527249,
umls-concept:C2911684
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2002-3-28
|
|
pubmed:abstractText |
We studied the prognostic value of thymidylate synthase (TS) expression in primary colorectal cancer (CRC) and the role of TS expression as a predictor of chemotherapeutic benefit in patients treated with adjuvant chemotherapy.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1721-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11919227-Adjuvants, Immunologic,
pubmed-meshheading:11919227-Aged,
pubmed-meshheading:11919227-Analysis of Variance,
pubmed-meshheading:11919227-Antimetabolites, Antineoplastic,
pubmed-meshheading:11919227-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11919227-Chemotherapy, Adjuvant,
pubmed-meshheading:11919227-Colorectal Neoplasms,
pubmed-meshheading:11919227-Disease-Free Survival,
pubmed-meshheading:11919227-Drug Administration Schedule,
pubmed-meshheading:11919227-Female,
pubmed-meshheading:11919227-Fluorouracil,
pubmed-meshheading:11919227-Gene Expression Regulation, Enzymologic,
pubmed-meshheading:11919227-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:11919227-Humans,
pubmed-meshheading:11919227-Immunohistochemistry,
pubmed-meshheading:11919227-Leucovorin,
pubmed-meshheading:11919227-Levamisole,
pubmed-meshheading:11919227-Male,
pubmed-meshheading:11919227-Middle Aged,
pubmed-meshheading:11919227-Neoplasm Staging,
pubmed-meshheading:11919227-Predictive Value of Tests,
pubmed-meshheading:11919227-Prognosis,
pubmed-meshheading:11919227-Proportional Hazards Models,
pubmed-meshheading:11919227-Survival Analysis,
pubmed-meshheading:11919227-Thymidylate Synthase,
pubmed-meshheading:11919227-Treatment Outcome,
pubmed-meshheading:11919227-Tumor Markers, Biological
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy.
|
|
pubmed:affiliation |
Department of Surgery, South Hospital, Stockholm, Sweden. david.edler@swipnet.se
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
